Tripković Ivo, Ogorevc Marin, Vuković Dubravka, Saraga-Babić Mirna, Mardešić Snježana
Department of Plastic Surgery, University Hospital Split, 21000 Split, Croatia.
Department of Anatomy, Histology and Embryology, University of Split School of Medicine, 21000 Split, Croatia.
Biomedicines. 2022 Dec 11;10(12):3214. doi: 10.3390/biomedicines10123214.
Carpal tunnel syndrome (CTS) and Dupuytren's disease (DD) are fibrotic conditions that affect the connective tissue of the hand and limit its functionality. The exact molecular mechanism underlying the fibrosis is unknown, and only some profibrotic factors have been investigated. In this cross-sectional study, we analyzed the expression of FGF signaling pathway molecules associated with fibrotic changes in the palmar fascia and the flexor retinaculum of 15 CTS patients and both clinically affected and unaffected palmar fascia of 15 DD patients, using immunofluorescence techniques. The expression of FGFR1, FGFR2, and CTGF in the blood vessel walls and surrounding connective tissue cells differed significantly between the analyzed groups, with changes in expression present even in clinically unremarkable tissues from DD patients. We also found altered expression of the analyzed factors, as well as TGF-β1 and syndecan-1 in DD-associated sweat glands, possibly implicating their role in the pathophysiology of the disease. The increased expression of profibrotic factors in the clinically unaffected palmar fascia of DD patients may indicate that more extensive excision is needed during surgical treatment, while the profibrotic factors could be potential targets for developing pharmacological therapeutic strategies against DD-associated fibrosis.
腕管综合征(CTS)和杜普伊特伦挛缩症(DD)是影响手部结缔组织并限制其功能的纤维化病症。纤维化的确切分子机制尚不清楚,仅对一些促纤维化因子进行了研究。在这项横断面研究中,我们使用免疫荧光技术分析了15例CTS患者掌腱膜和屈肌支持带中与纤维化变化相关的FGF信号通路分子的表达,以及15例DD患者临床受累和未受累的掌腱膜中该分子的表达。分析组之间血管壁和周围结缔组织细胞中FGFR1、FGFR2和CTGF的表达存在显著差异,即使在DD患者临床无明显异常的组织中也存在表达变化。我们还发现DD相关汗腺中分析的因子以及TGF-β1和syndecan-1的表达发生改变,这可能暗示它们在该疾病病理生理学中的作用。DD患者临床未受累掌腱膜中促纤维化因子表达增加可能表明手术治疗期间需要更广泛的切除,而促纤维化因子可能是开发针对DD相关纤维化的药物治疗策略的潜在靶点。